Stockscreener 앱 받기
47.29
13.83%
5.6525
전일 마감가:
$41.64
열려 있는:
$44.97
하루 거래량:
844.57K
Relative Volume:
1.39
시가총액:
$1.99B
수익:
$17.39M
순이익/손실:
$-135.89M
주가수익비율:
-10.19
EPS:
-4.64
순현금흐름:
$-123.00M
1주 성능:
+22.10%
1개월 성능:
+18.71%
6개월 성능:
-10.48%
1년 성능:
+108.90%
1일 변동 폭
$44.67
$48.21
1주일 범위
$38.51
$48.21
52주 변동 폭
$22.58
$57.28
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
명칭
Tarsus Pharmaceuticals Inc
전화
(949) 409-9820
주소
15440 LAGUNA CANYON ROAD, IRVINE
TARS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
47.28 | 1.73B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.78 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.99 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.97 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
670.10 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
296.30 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-27 | 재개 | H.C. Wainwright | Buy |
| 2023-11-20 | 개시 | Goldman | Neutral |
| 2023-07-18 | 개시 | William Blair | Outperform |
| 2023-05-18 | 개시 | Guggenheim | Buy |
| 2022-08-01 | 개시 | Barclays | Overweight |
| 2021-12-21 | 개시 | H.C. Wainwright | Buy |
| 2021-11-23 | 개시 | Oppenheimer | Outperform |
| 2020-11-10 | 개시 | BofA Securities | Buy |
| 2020-11-10 | 개시 | Jefferies | Buy |
| 2020-11-10 | 개시 | Ladenburg Thalmann | Buy |
| 2020-11-10 | 개시 | Raymond James | Strong Buy |
모두보기
Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스
Tarsus targets 95,000–100,000 bottles for Q3 2025 amid accelerated XDEMVY launch momentum - MSN
Tarsus Pharmaceuticals: Scaling a High-Growth Eye Care Platform with a Diversified Pipeline and Strong Commercial Execution - AInvest
Tarsus Pharmaceuticals Reports Record Sales Growth - TipRanks
Transcript : Tarsus Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Tarsus Pharmaceuticals : Second Quarter 2025 Earnings Presentation - MarketScreener
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 - The Globe and Mail
Tarsus Pharmaceuticals Reports Record $102.7 Million in Quarterly Net Product Sales of XDEMVY, a 152% Increase Year Over Year - Quiver Quantitative
Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements - Yahoo Finance
How does Tarsus Pharmaceuticals Inc. compare to its industry peersProven strategies for superior portfolio growth - Jammu Links News
What are the technical indicators suggesting about Tarsus Pharmaceuticals Inc.Maximize gains with timely market signals - Jammu Links News
Is Tarsus Pharmaceuticals Inc. stock overvalued or undervaluedRapid growth opportunities - Jammu Links News
Why is Tarsus Pharmaceuticals Inc. stock attracting strong analyst attentionBuild wealth steadily with smart stock selection - Jammu Links News
Is Tarsus Pharmaceuticals Inc. a good long term investmentUnlock powerful stock screening for profits - Jammu Links News
Is it the right time to buy Tarsus Pharmaceuticals Inc. stockGet ahead with breakthrough trading ideas - Jammu Links News
When is Tarsus Pharmaceuticals Inc. stock expected to show significant growthAchieve rapid financial growth with smart picks - Jammu Links News
What is the dividend policy of Tarsus Pharmaceuticals Inc. stockUnlock your portfolio’s full growth potential - Jammu Links News
What are the latest earnings results for Tarsus Pharmaceuticals Inc.Phenomenal returns - Jammu Links News
What analysts say about Tarsus Pharmaceuticals Inc. stockBuild a portfolio that withstands market volatility - Jammu Links News
What institutional investors are buying Tarsus Pharmaceuticals Inc. stockInvest confidently with market-leading analysis - Jammu Links News
How strong is Tarsus Pharmaceuticals Inc. company’s balance sheetAchieve breakthrough financial results - Jammu Links News
What makes Tarsus Pharmaceuticals Inc. stock price move sharplyFree Stock Review Backed By Experts - jammulinksnews.com
Is Tarsus Pharmaceuticals Inc. a growth stock or a value stockChart Pattern Data Feed For Beginners - jammulinksnews.com
Tarsus Pharmaceuticals, Inc. to Host Live Webcast for Q2 2025 Financial Results and Corporate Update - Quiver Quantitative
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 - GlobeNewswire Inc.
Why Investors Shouldn't Be Surprised By Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) P/S - simplywall.st
Tarsus Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayWeekly Return Pick Forecast Reports Show Trend - metal.it
Tarsus Pharmaceuticals Inc. Charts Flash Early Recovery SignalsNews Based Entry Opportunity Alerts Detected - metal.it
Tarsus Pharmaceuticals Inc. Facing Inflection Point in Trend AnalysisLong Hold Safe Return Strategy Reviewed - metal.it
Wyckoff Accumulation Phase Possible in Tarsus Pharmaceuticals Inc.Chart-Based Trade Entries Gain Analyst Support - metal.it
Evaluating Tarsus Pharmaceuticals Inc. with trendline analysisTechnical Screener for High Growth Stocks - Newser
How Resilient Is Tarsus Pharmaceuticals Inc. Stock During Economic DownturnsBuy Strategy Tracker with Growth Indicators - Newser
Tarsus Pharmaceuticals Inc. Attempts Reversal From Key SupportChart Driven High Reward Trading Setup Presented - metal.it
Why Tarsus Pharmaceuticals Inc. stock attracts strong analyst attentionTrade Safety Matrix for Conservative Traders - Newser
Published on: 2025-07-28 23:18:28 - metal.it
Fibonacci Levels Suggest Recovery for Tarsus Pharmaceuticals Inc.Weekly Chart Analysis With Entry Advice Provided - metal.it
How volatile is Tarsus Pharmaceuticals Inc. stock compared to the marketTriple-digit profit margins - jammulinksnews.com
Published on: 2025-07-27 21:08:22 - Jammu Links News
Tarsus Pharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsFree Access to Community - metal.it
How does Tarsus Pharmaceuticals Inc. generate profit in a changing economyCapitalize on market trends with confidence - jammulinksnews.com
Buy Signal for Tarsus Pharmaceuticals Inc. Stock Key Technical Indicators to WatchPotential Rocket List - metal.it
How Interest Rate Changes Impact Tarsus Pharmaceuticals Inc. Stock PerformanceMomentum Swing Watchlist - Newser
What is the risk reward ratio of investing in Tarsus Pharmaceuticals Inc. stockDiscover the next big stock winners - jammulinksnews.com
Bank of New York Mellon Corp Sells 915 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Should I buy Tarsus Pharmaceuticals Inc. stock before earningsHigh-yield investments - Jammu Links News
When is the best time to buy Tarsus Pharmaceuticals Inc. stockHigh-yield market plays - jammulinksnews.com
Tarsus Pharmaceuticals Inc (TARS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.28%
2.25%
자본화:
|
볼륨(24시간):